$AIP

Bayview Legacy, LLC sold $8.2M of AIP (indirect holdings)

Bayview Legacy, LLC sold 181,338 indirectly-held shares of Arteris, Inc. (AIP) at an average of $45.46 ($44.06–$47.08, $8.24M total) across 4 trades on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bayview Legacy, LLC
Published Jul 2, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 7:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

A 10b5-1 open-market sale of 181,338 shares (about $8.24M) was executed on 2026-07-01 and reported on 2026-07-02, which may slightly pressure sentiment but does not constitute new operational or financial guidance.

02

Market read

Traders may monitor for follow-on filings, but this specific disclosure is unlikely to change valuation absent other catalysts.

03

What to watch

Indirect holdings and multiple small lots can obscure the true economic exposure; traders should avoid inferring directionality without corroborating fundamentals or additional filings.

Relevance 5/10Novelty 3/10Timing: filed 2026-07-02 for a sale executed 2026-07-01

Background

The article is an SEC Form 4 insider transaction disclosure for Arteris, Inc., reported by Bayview Legacy, LLC as a 10% owner with indirect holdings.

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Arteris, Inc. (AIP) disclosed a 10b5-1 indirect open-market sale by Bayview Legacy totaling about $8.24M at ~$45.46/share.

Expected impact

Near-term impact is likely limited; any reaction would be sentiment-driven and could fade as traders discount 10b5-1.

Evidence & confidence

Form 4 shows sale size and pricing range, but the presence of a pre-arranged 10b5-1 plan reduces the likelihood of immediate new information about company prospects.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the trades are explicitly under a pre-arranged 10b5-1 plan, the sale may reflect liquidity planning rather than bearish expectations, so price impact may be overstated.

Key entities

  • Arteris, Inc.

    Subject of the Form 4 insider transaction disclosure (AIP).

  • Bayview Legacy, LLC

    Reporter of the indirect open-market sale under a pre-arranged 10b5-1 plan.

  • 10b5-1 plan

    Pre-arranged plan that typically reduces the informational content of insider sales.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to